Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection

BACKGROUND: Fingolimod, a sphingosine-1-phosphate receptor modulator with well-described immunomodulatory properties involving peripheral immune cell trafficking, was the first oral agent approved for the treatment of relapsing remitting multiple sclerosis. Analogous immunomodulatory treatment optio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrosius, Björn, Pitarokoili, Kalliopi, Schrewe, Lisa, Pedreiturria, Xiomara, Motte, Jeremias, Gold, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406994/
https://www.ncbi.nlm.nih.gov/pubmed/28446186
http://dx.doi.org/10.1186/s12974-017-0864-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406994/
https://www.ncbi.nlm.nih.gov/pubmed/28446186
http://dx.doi.org/10.1186/s12974-017-0864-z

Ejemplares similares